ILOSONE SULFA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ilosone Sulfa, and what generic alternatives are available?
Ilosone Sulfa is a drug marketed by Lilly and is included in one NDA.
The generic ingredient in ILOSONE SULFA is erythromycin estolate; sulfisoxazole acetyl. There is one drug master file entry for this compound. Additional details are available on the erythromycin estolate; sulfisoxazole acetyl profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ILOSONE SULFA?
- What are the global sales for ILOSONE SULFA?
- What is Average Wholesale Price for ILOSONE SULFA?
Summary for ILOSONE SULFA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | ILOSONE SULFA at DailyMed |
US Patents and Regulatory Information for ILOSONE SULFA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lilly | ILOSONE SULFA | erythromycin estolate; sulfisoxazole acetyl | SUSPENSION;ORAL | 050599-001 | Sep 29, 1989 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
